Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


05.11.2018

2 BJU Int
1 BMC Cancer
1 Br J Cancer
4 Br J Radiol
1 Cancer Imaging
5 Eur Urol
2 J Cell Physiol
1 J Natl Cancer Inst
1 Nat Rev Urol
2 PLoS One
1 Prog Urol
2 Prostate
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int

  1. ORCZYK C, Villers A, Rusinek H, Lepennec V, et al
    Prostate cancer heterogeneity: texture analysis score based on multiple MRI sequences for detection, stratification and selection of lesions at time of biopsy.
    BJU Int. 2018 Oct 30. doi: 10.1111/bju.14603.
    PubMed     Text format     Abstract available

  2. COLLINS A, Sundararajan V, Millar J, Burchell J, et al
    The trajectory of people who die from metastatic prostate cancer: A population-based study.
    BJU Int. 2018 Oct 29. doi: 10.1111/bju.14593.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. CHUNG DY, Koh DH, Goh HJ, Kim MS, et al
    Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.
    BMC Cancer. 2018;18:1057.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. AL-SAFFAR NMS, Troy H, Wong Te Fong AC, Paravati R, et al
    Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma.
    Br J Cancer. 2018 Oct 31. pii: 10.1038/s41416-018-0242.
    PubMed     Text format     Abstract available


    Br J Radiol

  5. TAU N, Berlin A, Yeung I, Halankar J, et al
    Quantitative assessment of dynamic (18)F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.
    Br J Radiol. 2018 Nov 1:20180568. doi: 10.1259/bjr.20180568.
    PubMed     Text format     Abstract available

  6. JERECZEK-FOSSA BA, Rojas DP, Zerini D, Fodor C, et al
    Re-irradiation for isolated local recurrence of prostate cancer: MONO-INSTITUTIONAL series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
    Br J Radiol. 2018 Oct 31:20180494. doi: 10.1259/bjr.20180494.
    PubMed     Text format     Abstract available

  7. MULLANEY L, O'Shea E, Dunne MT, Thirion PG, et al
    A comparison of bladder volumes based on treatment planning Computed Tomography and BladderScan(R) BVI 6100 ultrasound device in a prostate radiation therapy population.
    Br J Radiol. 2018 Jun 11:20180160. doi: 10.1259/bjr.20180160.
    PubMed     Text format     Abstract available

  8. TURNER JH
    Recent advances in theranostics and challenges for the future.
    Br J Radiol. 2018;91:20170893.
    PubMed     Text format     Abstract available


    Cancer Imaging

  9. KEIDAR Z, Gill R, Goshen E, Israel O, et al
    68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
    Cancer Imaging. 2018;18:39.
    PubMed     Text format     Abstract available


    Eur Urol

  10. MONTIRONI R, Cheng L, Scarpelli M, Lopez-Beltran A, et al
    From Gleason Grading System and High-grade Tertiary Patterns to Grade Groups and Integrated Quantitative Gleason Score.
    Eur Urol. 2018;73:684-686.
    PubMed     Text format    

  11. CHIN JL
    Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
    Eur Urol. 2018;73:808.
    PubMed     Text format    

  12. AVULOVA S, Smith JA Jr
    Is Comparison of Robotic to Open Radical Prostatectomy Still Relevant?
    Eur Urol. 2018;73:672-673.
    PubMed     Text format    

  13. CAMPODONICO F, Ennas M, Introini C
    Re: Ettore Di Trapani, Alessandro Nini, Irene Locatelli, et al. Development of the First Model of Radical Prostatectomy in the Mouse: A Feasibility Study. Eur Urol 2018;73:482-4.
    Eur Urol. 2018;73:e133.
    PubMed     Text format    

  14. BRATT O, Lamb AD
    Genetic Reasons to Walk the Extra Mile to Prevent Prostate Cancer.
    Eur Urol. 2018 Oct 29. pii: S0302-2838(18)30807.
    PubMed     Text format    


    J Cell Physiol

  15. TADDEI ML, Cavallini L, Ramazzotti M, Comito G, et al
    Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy.
    J Cell Physiol. 2018 Oct 30. doi: 10.1002/jcp.27679.
    PubMed     Text format     Abstract available

  16. MADRIGAL-MARTINEZ A, Constancio V, Lucio-Cazana FJ, Fernandez-Martinez AB, et al
    PROSTAGLANDIN E2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2.
    J Cell Physiol. 2018 Oct 26. doi: 10.1002/jcp.27515.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  17. WALSH PC
    RE: Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Oct 30. pii: 5149366. doi: 10.1093.
    PubMed     Text format    


    Nat Rev Urol

  18. K CHAMBERS S, Heathcote P
    The psychological toll of prostate cancer.
    Nat Rev Urol. 2018 Nov 1. pii: 10.1038/s41585-018-0111.
    PubMed     Text format    


    PLoS One

  19. BABALYAN K, Sultanov R, Generozov E, Sharova E, et al
    LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer.
    PLoS One. 2018;13:e0204371.
    PubMed     Text format     Abstract available

  20. ZHANG S, Zheng C, Yao S, Wang Z, et al
    Proteomic analysis of human prostate cancer PC-3M-1E8 cells and PC-3M-2B4 cells of same origin but with different metastatic potential.
    PLoS One. 2018;13:e0206139.
    PubMed     Text format     Abstract available


    Prog Urol

  21. SARRADIN M, Lepiney C, Celhay O, Delpech PO, et al
    [Estimating minimum period of time to perform prostate MRI after prostate biopsy: Clinical and histological bleeding risk factors; from a prospective study].
    Prog Urol. 2018;28:85-93.
    PubMed     Text format     Abstract available


    Prostate

  22. MIYAHIRA AK, Den RB, Carlo MI, de Leeuw R, et al
    Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
    Prostate. 2018 Oct 31. doi: 10.1002/pros.23729.
    PubMed     Text format     Abstract available

  23. LAVOIE JM, Zou K, Khalaf D, Eigl BJ, et al
    Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysis.
    Prostate. 2018 Oct 28. doi: 10.1002/pros.23733.
    PubMed     Text format     Abstract available


    Urology

  24. QUARRIER SO, Matloubieh JE, Wu G
    Robot-Assisted Placement of Pelvic Tissue Expander for Radiation after Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence.
    Urology. 2018 Oct 29. pii: S0090-4295(18)31068.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: